BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35675485)

  • 41. Inhibition of vascular neointima hyperplasia by FGF21 associated with FGFR1/Syk/NLRP3 inflammasome pathway in diabetic mice.
    Wei W; Li XX; Xu M
    Atherosclerosis; 2019 Oct; 289():132-142. PubMed ID: 31513948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy.
    Du L; Wang J; Chen Y; Li X; Wang L; Li Y; Jin X; Gu X; Hao M; Zhu X; Yin X; Lu Q
    Cell Biol Toxicol; 2020 Jun; 36(3):243-260. PubMed ID: 31768838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peperomin E (PepE) protects against high fat diet-induced atherosclerosis in Apolipoprotein E deficient (ApoE
    Yan J; Li M; Wang XD; Lu ZY; Ni XL
    Biomed Pharmacother; 2018 Sep; 105():862-869. PubMed ID: 30021379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Visfatin/eNampt induces endothelial dysfunction in vivo: a role for Toll-Like Receptor 4 and NLRP3 inflammasome.
    Romacho T; Valencia I; Ramos-González M; Vallejo S; López-Esteban M; Lorenzo O; Cannata P; Romero A; San Hipólito-Luengo A; Gómez-Cerezo JF; Peiró C; Sánchez-Ferrer CF
    Sci Rep; 2020 Mar; 10(1):5386. PubMed ID: 32214150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline.
    Chen W; Zhao M; Zhao S; Lu Q; Ni L; Zou C; Lu L; Xu X; Guan H; Zheng Z; Qiu Q
    Inflamm Res; 2017 Feb; 66(2):157-166. PubMed ID: 27785530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Carbenoxolone Ameliorates Allergic Airway Inflammation through NF-κB/NLRP3 Pathway in Mice.
    He F; Cheng Q; Li N; Shang Y
    Biol Pharm Bull; 2022 Jun; 45(6):743-750. PubMed ID: 35431287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production.
    Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z
    J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Staphylococcal Enterotoxin A Induces Intestinal Barrier Dysfunction and Activates NLRP3 Inflammasome via NF-κB/MAPK Signaling Pathways in Mice.
    Liu C; Chi K; Yang M; Guo N
    Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051006
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NLRP3 inflammasome activation regulated by NF-κB and DAPK contributed to paraquat-induced acute kidney injury.
    Liu Z; Wang X; Wang Y; Zhao M
    Immunol Res; 2017 Jun; 65(3):687-698. PubMed ID: 28215032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ablation of Neuropilin 1 in Myeloid Cells Exacerbates High-Fat Diet-Induced Insulin Resistance Through Nlrp3 Inflammasome In Vivo.
    Dai X; Okon I; Liu Z; Bedarida T; Wang Q; Ramprasath T; Zhang M; Song P; Zou MH
    Diabetes; 2017 Sep; 66(9):2424-2435. PubMed ID: 28659345
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy.
    Yi H; Peng R; Zhang LY; Sun Y; Peng HM; Liu HD; Yu LJ; Li AL; Zhang YJ; Jiang WH; Zhang Z
    Cell Death Dis; 2017 Feb; 8(2):e2583. PubMed ID: 28151474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of NLRP3 inflammasome by CD38 through cADPR-mediated Ca
    Li JP; Wei W; Li XX; Xu M
    Life Sci; 2020 Aug; 255():117758. PubMed ID: 32407845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dimethyl fumarate ameliorates diabetes-associated vascular complications through ROS-TXNIP-NLRP3 inflammasome pathway.
    Amin FM; Abdelaziz RR; Hamed MF; Nader MA; Shehatou GSG
    Life Sci; 2020 Sep; 256():117887. PubMed ID: 32497629
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NLRP3 Inflammasome Mediates Aldosterone-Induced Vascular Damage.
    Bruder-Nascimento T; Ferreira NS; Zanotto CZ; Ramalho F; Pequeno IO; Olivon VC; Neves KB; Alves-Lopes R; Campos E; Silva CA; Fazan R; Carlos D; Mestriner FL; Prado D; Pereira FV; Braga T; Luiz JP; Cau SB; Elias PC; Moreira AC; Câmara NO; Zamboni DS; Alves-Filho JC; Tostes RC
    Circulation; 2016 Dec; 134(23):1866-1880. PubMed ID: 27803035
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Paeoniflorin relieves LPS-induced inflammatory pain in mice by inhibiting NLRP3 inflammasome activation via transient receptor potential vanilloid 1.
    Yin N; Gao Q; Tao W; Chen J; Bi J; Ding F; Wang Z
    J Leukoc Biol; 2020 Jul; 108(1):229-241. PubMed ID: 32083340
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of NLRP3-Inflammasome/Caspase-1/Galectin-3 Pathway on Atrial Remodeling in Diabetic Rabbits.
    Wu X; Liu Y; Tu D; Liu X; Niu S; Suo Y; Liu T; Li G; Liu C
    J Cardiovasc Transl Res; 2020 Oct; 13(5):731-740. PubMed ID: 32048199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cannabidiol protects livers against nonalcoholic steatohepatitis induced by high-fat high cholesterol diet via regulating NF-κB and NLRP3 inflammasome pathway.
    Huang Y; Wan T; Pang N; Zhou Y; Jiang X; Li B; Gu Y; Huang Y; Ye X; Lian H; Zhang Z; Yang L
    J Cell Physiol; 2019 Nov; 234(11):21224-21234. PubMed ID: 31032942
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart.
    Fender AC; Kleeschulte S; Stolte S; Leineweber K; Kamler M; Bode J; Li N; Dobrev D
    Basic Res Cardiol; 2020 Jan; 115(2):10. PubMed ID: 31912235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complanatoside A targeting NOX4 blocks renal fibrosis in diabetic mice by suppressing NLRP3 inflammasome activation and autophagy.
    Ren C; Bao X; Lu X; Du W; Wang X; Wei J; Li L; Li X; Lin X; Zhang Q; Ma B
    Phytomedicine; 2022 Sep; 104():154310. PubMed ID: 35843189
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NLRX1 knockout aggravates lipopolysaccharide (LPS)-induced heart injury and attenuates the anti-LPS cardioprotective effect of CYP2J2/11,12-EET by enhancing activation of NF-κB and NLRP3 inflammasome.
    Zhao G; Wang X; Edwards S; Dai M; Li J; Wu L; Xu R; Han J; Yuan H
    Eur J Pharmacol; 2020 Aug; 881():173276. PubMed ID: 32574674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.